Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (5): 651-660.doi: 10.19982/j.issn.1000-6621.20260001
• Original Articles • Previous Articles Next Articles
Meng Ting1, Chen Jingfang1,2(
), Deng Guofang3, Lin Yi3, Yuan Jinsong1, Ma Mengting1
Received:2026-01-02
Online:2026-05-10
Published:2026-04-27
Contact:
Chen Jingfang
E-mail:13823139640@163.com
Supported by:CLC Number:
Meng Ting, Chen Jingfang, Deng Guofang, Lin Yi, Yuan Jinsong, Ma Mengting. Analysis of current status of mental vulnerability of tuberculosis patients and its influencing factors[J]. Chinese Journal of Antituberculosis, 2026, 48(5): 651-660. doi: 10.19982/j.issn.1000-6621.20260001
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20260001
| 分类 | 患者例数 | 心理脆弱平均得分(分, | 统计检验值 | P值 | |||||
|---|---|---|---|---|---|---|---|---|---|
| 性别 | t=0.714 | 0.475 | |||||||
| 男性 | 532 | 56.28±11.23 | |||||||
| 女性 | 275 | 55.69±10.66 | |||||||
| 年龄组(岁) | F=10.222 | <0.001 | |||||||
| 18~40 | 339 | 54.04±10.26 | |||||||
| 41~65 | 357 | 57.59±10.65 | |||||||
| >65 | 111 | 57.45±13.38 | |||||||
| 婚姻状况 | F=11.465 | <0.001 | |||||||
| 未婚 | 204 | 52.94±10.44 | |||||||
| 已婚 | 578 | 57.11±11.06 | |||||||
| 离异或丧偶 | 25 | 58.04±10.51 | |||||||
| 文化程度 | F=2.916 | 0.033 | |||||||
| 小学及以下 | 157 | 57.75±11.73 | |||||||
| 初中 | 263 | 56.49±10.58 | |||||||
| 高中 | 173 | 55.97±11.41 | |||||||
| 大学及以上 | 214 | 54.44±10.58 | |||||||
| 居住地 | t=1.062 | 0.289 | |||||||
| 农村 | 471 | 56.43±11.01 | |||||||
| 城镇 | 336 | 55.59±11.06 | |||||||
| 居住情况 | t=-3.324 | <0.001 | |||||||
| 独居 | 223 | 54.00±11.12 | |||||||
| 与家人同居 | 584 | 56.87±10.91 | |||||||
| 家庭人均月收入(元) | F=0.715 | 0.490 | |||||||
| <5000 | 334 | 56.40±10.69 | |||||||
| 5000~10000 | 369 | 55.59±11.12 | |||||||
| >10000 | 104 | 56.80±11.80 | |||||||
| 工作状态 | t=2.537 | 0.011 | |||||||
| 无业 | 477 | 56.90±11.33 | |||||||
| 在职 | 330 | 54.90±10.50 | |||||||
| 结核病分类 | F=4.267 | 0.014 | |||||||
| 肺结核 | 573 | 56.78±10.81 | |||||||
| 肺外结核 | 76 | 53.62±10.25 | |||||||
| 肺结核并发肺外结核 | 158 | 54.73±11.94 | |||||||
| 治疗分类 | t=1.575 | 0.116 | |||||||
| 初治 | 701 | 56.32±10.80 | |||||||
| 复治 | 106 | 54.51±12.40 | |||||||
| 确诊时间a | F=1.191 | 0.304 | |||||||
| <2个月 | 379 | 56.63±9.43 | |||||||
| 2~6个月 | 143 | 55.05±12.48 | |||||||
| >6个月 | 285 | 55.73±12.58 | |||||||
| 耐药情况 | F=14.950 | <0.001 | |||||||
| 敏感 | 707 | 55.30±10.76 | |||||||
| 单耐药 | 47 | 60.72±11.49 | |||||||
| 耐多药 | 53 | 62.34±11.46 | |||||||
| 并发症 | t=-12.361 | <0.001 | |||||||
| 无 | 480 | 52.45±10.88 | |||||||
| 有 | 327 | 61.42±8.88 | |||||||
| 吸烟史b | t=-1.238 | 0.216 | |||||||
| 无 | 510 | 55.71±10.82 | |||||||
| 有 | 297 | 56.71±11.38 | |||||||
| 饮酒史c | t=-0.654 | 0.513 | |||||||
| 无 | 686 | 55.97±11.10 | |||||||
| 有 | 121 | 56.69±10.69 | |||||||
| 项目 | 心理脆弱总分 | 身心症状 | 精神症状 | 人际问题 | ||||
|---|---|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
| 焦虑抑郁总分 | 0.136 | <0.001 | 0.114 | 0.001 | 0.115 | 0.001 | 0.117 | <0.001 |
| 焦虑 | 0.116 | <0.001 | 0.094 | 0.007 | 0.101 | 0.004 | 0.106 | 0.002 |
| 抑郁 | 0.154 | <0.001 | 0.136 | <0.001 | 0.127 | <0.001 | 0.122 | <0.001 |
| 疾病感知总分 | 0.105 | 0.003 | 0.095 | 0.007 | 0.097 | 0.006 | 0.060 | 0.090 |
| 认知表征 | 0.102 | 0.004 | 0.096 | 0.007 | 0.093 | 0.008 | 0.049 | 0.162 |
| 情绪表征 | -0.044 | 0.208 | -0.013 | 0.718 | -0.035 | 0.318 | -0.107 | 0.002 |
| 对疾病了解程度 | 0.124 | <0.001 | 0.070 | 0.046 | 0.104 | 0.003 | 0.197 | <0.001 |
| 领悟社会支持总分 | -0.741 | <0.001 | -0.674 | <0.001 | -0.651 | <0.001 | -0.462 | <0.001 |
| 家庭支持 | -0.741 | <0.001 | -0.676 | <0.001 | -0.667 | <0.001 | -0.426 | <0.001 |
| 朋友支持 | -0.770 | <0.001 | -0.711 | <0.001 | -0.689 | <0.001 | -0.425 | <0.001 |
| 其他支持 | -0.782 | <0.001 | -0.723 | <0.001 | -0.698 | <0.001 | -0.437 | <0.001 |
| 变量 | 赋值 |
|---|---|
| 年龄 | 18~40岁(Z1=0,Z2=0);41~65岁(Z1=1,Z2=0);>65岁(Z1=0,Z2=1) |
| 婚姻状况 | 未婚(Z1=0,Z2=0);已婚(Z1=1,Z2=0);离异或丧偶(Z1=0,Z2=1) |
| 文化程度 | 小学及以下(Z1=0,Z2=0,Z3=0);初中(Z1=1,Z2=0,Z3=0),高中(Z1=0,Z2=1,Z3=0);大学及以上(Z1=0,Z2=0,Z3=1) |
| 居住情况 | 独居=0;与家人同居=1 |
| 工作状态 | 无业=0;在职=1 |
| 结核病分类 | 肺结核(Z1=0,Z2=0);肺外结核(Z1=1,Z2=0);肺结核并发肺外结核(Z1=0,Z2=1) |
| 耐药情况 | 敏感(Z1=0,Z2=0);单耐药(Z1=1,Z2=0);耐多药(Z1=0,Z2=1) |
| 并发症 | 无=0;有=1 |
| 焦虑抑郁 | 原始数值录入 |
| 疾病感知 | 原始数值录入 |
| 领悟社会支持 | 原始数值录入 |
| 变量 | β值 | 标准误 | 标准化β值 | t值 | P值 | 95%CI值 | 容差 | VIF值 |
|---|---|---|---|---|---|---|---|---|
| 年龄(参照:18~40岁) | ||||||||
| 41~65岁 | 1.437 | 0.814 | 0.065 | 1.766 | 0.078 | -0.160~3.034 | 0.364 | 2.749 |
| >65岁 | 2.081 | 1.042 | 0.093 | 1.998 | 0.046 | 0.036~4.126 | 0.225 | 4.449 |
| 耐药情况(参照:敏感) | ||||||||
| 单耐药 | 3.016 | 1.054 | 0.064 | 2.861 | 0.004 | 0.947~5.084 | 0.975 | 1.025 |
| 耐多药 | 4.137 | 1.002 | 0.093 | 4.130 | <0.001 | 2.171~6.104 | 0.965 | 1.036 |
| 并发症(参照:无并发症) | ||||||||
| 有并发症 | 4.843 | 0.588 | 0.216 | 8.231 | <0.001 | 3.688~5.998 | 0.712 | 1.404 |
| 社会支持 | -12.365 | 0.426 | -0.673 | -28.992 | <0.001 | -13.202~-11.527 | 0.906 | 1.103 |
| 分类 | 初治患者(701例) | 复治患者(106例) | χ2值 | P值 | ||
|---|---|---|---|---|---|---|
| 性别 | 4.953 | 0.026 | ||||
| 男性 | 452(64.48) | 80(75.47) | ||||
| 女性 | 249(35.52) | 26(24.53) | ||||
| 年龄组(岁) | 5.839 | 0.054 | ||||
| 18~40 | 304(43.37) | 35(33.02) | ||||
| 41~65 | 307(43.79) | 50(47.17) | ||||
| >65 | 90(12.84) | 21(19.81) | ||||
| 婚姻状况 | 0.517 | 0.772 | ||||
| 未婚 | 180(25.68) | 24(22.64) | ||||
| 已婚 | 499(71.18) | 79(74.53) | ||||
| 离异或丧偶 | 22(3.14) | 3(2.83) | ||||
| 文化程度 | 8.253 | 0.041 | ||||
| 小学及以下 | 126(17.87) | 31(29.25) | ||||
| 初中 | 229(32.67) | 34(32.08) | ||||
| 高中 | 154(21.97) | 19(17.92) | ||||
| 大学及以上 | 192(27.39) | 22(20.75) | ||||
| 居住地 | 16.362 | <0.001 | ||||
| 农村 | 390(55.63) | 81(76.42) | ||||
| 城镇 | 311(44.37) | 25(23.58) | ||||
| 居住情况 | 0.005 | 0.946 | ||||
| 独居 | 194(27.67) | 29(27.36) | ||||
| 与家人同居 | 507(72.33) | 77(72.64) | ||||
| 家庭人均月收入(元) | 6.693 | 0.035 | ||||
| <5000 | 278(39.66) | 56(52.83) | ||||
| 5000~10000 | 329(46.93) | 40(37.74) | ||||
| >10000 | 94(13.41) | 10(9.43) | ||||
| 工作状态 | 3.130 | 0.077 | ||||
| 无业 | 406(57.92) | 71(66.98) | ||||
| 在职 | 295(42.08) | 35(33.02) | ||||
| 结核病分类 | 2.501 | 0.286 | ||||
| 肺结核 | 491(70.04) | 82(77.36) | ||||
| 肺外结核 | 141(20.12) | 17(16.04) | ||||
| 肺结核并发肺外结核 | 69(9.84) | 7(6.60) | ||||
| 确诊时间 | 181.605 | <0.001 | ||||
| <2个月 | 378(53.92) | 1(0.94) | ||||
| 2~6个月 | 137(19.55) | 6(5.66) | ||||
| >6个月 | 186(26.53) | 99(93.40) | ||||
| 耐药情况 | 32.043 | <0.001 | ||||
| 敏感 | 632(90.15) | 75(70.75) | ||||
| 单耐药 | 33(4.71) | 14(13.21) | ||||
| 耐多药 | 36(5.14) | 17(16.04) | ||||
| 并发症 | 1.648 | 0.199 | ||||
| 无 | 423(60.34) | 57(53.77) | ||||
| 有 | 278(39.66) | 49(46.23) | ||||
| 吸烟史 | 2.980 | 0.084 | ||||
| 无 | 451(64.34) | 59(55.66) | ||||
| 有 | 250(35.66) | 47(44.34) | ||||
| 饮酒史 | 0.822 | 0.364 | ||||
| 无 | 599(85.45) | 87(82.08) | ||||
| 有 | 102(14.55) | 19(17.92) | ||||
| 变量 | 初治组(701例) | 复治组(106例) | ||
|---|---|---|---|---|
| β (95%CI)值 | P值 | β (95%CI)值 | P值 | |
| 领悟社会支持 | -0.661(-0.701~-0.622) | <0.001 | -0.687(-0.792~-0.582) | <0.001 |
| 耐多药(参照:敏感) | 1.815(-0.289~3.918) | 0.091 | 6.248(2.699~9.796) | 0.001 |
| 有并发症(参照:无并发症) | 4.605(3.576~5.634) | <0.001 | 4.261(1.397~7.126) | 0.004 |
| 城镇居住(参照:农村) | -0.548(-1.771~0.674) | 0.379 | -4.431(-7.902~-0.960) | 0.013 |
| [1] | 胡鑫洋, 高静韬. 世界卫生组织《2024年全球结核病报告》解读. 结核与肺部疾病杂志, 2024, 5(6): 500-504. doi:10.19983/j.issn.2096-8493.2024164. |
| [2] |
Long Q, Guo L, Jiang W, et al. Ending tuberculosis in China: health system challenges. Lancet Public Health, 2021, 6(12): e948-e953. doi:10.1016/S2468-2667(21)00203-6.
pmid: 34838198 |
| [3] |
Chen X, Du L, Wu R, et al. Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study. BMC public health, 2021, 21(1): 6. doi:10.1186/s12889-020-10055-2.
pmid: 33397334 |
| [4] |
Eplov LF, Jørgensen T, Birket-Smith M, et al. Mental vulnerability as a predictor of early mortality. Epidemiology, 2005, 16(2): 226-232. doi:10.1097/01.ede.0000152904.95284.0f.
pmid: 15703538 |
| [5] | Jørgensen TSH, Wium-Andersen MK, Jørgensen MB, et al. The impact of mental vulnerability on the relationship between cardiovascular disease and depression. Eur Psychiatry, 2020, 63(1): e16. doi:10.1192/j.eurpsy.2020.20. |
| [6] |
Chen X, Wu R, Xu J, et al. Prevalence and associated factors of psychological distress in tuberculosis patients in Northeast China: a cross-sectional study. BMC Infect Dis, 2021, 21(1): 563. doi:10.1186/s12879-021-06284-4.
pmid: 34118910 |
| [7] |
Banholzer N, Muula G, Mureithi F, et al. Mental, physical, and respiratory health in people with tuberculosis in Southern Africa: a multi-country cohort analysis. BMC Med, 2025, 23(1): 485. doi:10.1186/s12916-025-04321-6.
pmid: 40830471 |
| [8] |
Østergaard D, Dalton SO, Bidstrup PE, et al. Mental vulnera-bility as a risk factor for depression: a prospective cohort study in Denmark. Int J Soc Psychiatry, 2012, 58(3): 306-314. doi:10.1177/0020764010396409.
pmid: 21441278 |
| [9] |
Yani DI, Pujhiyani PS, Rahayu ES, et al. Assessing Quality of Life in Patients with New and Recurrent Pulmonary Tuberculosis: A Cross-Sectional Study from Garut, Indonesia. Iran J Nurs Midwifery Res, 2025, 30(3): 447-448. doi:10.4103/ijnmr.ijnmr_373_21.
pmid: 40520391 |
| [10] | 中国疾病预防控制中心结核病预防控制中心. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021. |
| [11] |
Green SB. How Many Subjects Does It Take To Do A Regression Analysis. Multivariate Behav Res, 1991, 26(3): 499-510. doi:10.1207/s15327906mbr2603_7.
pmid: 26776715 |
| [12] | Eplov LF, Petersen J, Jørgensen T, et al. The Mental Vulnerability Questionnaire: a psychometric evaluation. Scand J Psychol, 2010, 51(6): 548-554. doi:10.1111/j.1467-9450.2010.00834.x. |
| [13] | 公雨欣, 刘堃, 扈娜, 等. 修正版心理脆弱量表汉化后的信效度评价. 现代预防医学, 2019, 46(4): 683-686. |
| [14] | Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand, 1983, 67(6): 361-370. doi:10.1111/j.1600-0447.1983.tb09716.x. |
| [15] | Anye LC, Agbortabot BME, Njundah AL, et al. Depression, anxiety and medication adherence among tuberculosis patients attending treatment centres in Fako Division, Cameroon: cross-sectional study. BJPsych Qpen, 2023, 9(3): e65. doi:10.1192/bjo.2023.42. |
| [16] |
Kumpuangdee S, Roomruangwong C, Sophonphan J, et al. Prevalence of depression and anxiety in pulmonary tuberculosis patients and its association with unsuccessful treatment outcome: A prospective cohort study. Indian J Tuberc, 2023, 70(3): 297-302. doi:10.1016/j.ijtb.2022.05.007.
pmid: 37562903 |
| [17] |
Broadbent E, Petrie KJ, Main J, et al. The brief illness perception questionnaire. J Psychosom Res, 2006, 60(6): 631-637. doi:10.1016/j.jpsychores.2005.10.020.
pmid: 16731240 |
| [18] |
Lukoševičiūtė J, Šmigelskas K. Causal item of Brief Illness Perception Questionnaire (BIPQ) scale: The main categories. Health Psychol Res, 2020, 8(1): 8485. doi:10.4081/hpr.2020.8485.
pmid: 32529089 |
| [19] | 况培, 林莹, 龙良平, 等. 子宫内膜异位症患者恐惧疾病进展现状及影响因素分析. 护士进修杂志, 2026, 41(6):581-586. doi:10.16821/j.cnki.hsjx.2026.06.003. |
| [20] | Zimet GD, Powell SS, Farley GK, et al. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess, 1990, 55(3/4): 610-617. doi:10.1080/00223891.1990.9674095. |
| [21] | 张帆, 朱树贞, 邓平基. 领悟社会支持量表在国内住院病人社会支持研究中的应用评价. 护理研究, 2018, 32(13): 2048-2052. doi:10.12102/j.issn.1009-6493.2018.13.015. |
| [22] | 江佳隆, 李贤. 老年脑卒中病人心理脆弱现状及影响因素. 护理研究, 2021, 35(3): 387-390. doi:10.12102/j.issn.1009-6493.2021.03.003. |
| [23] | 关永莲, 顾毅, 蒋影. 老年维持性血液透析病人心理脆弱现状及其与希望水平和社会影响的相关性. 护理研究, 2022, 36(22): 3977-3981. doi:10.12102/j.issn.1009-6493.2022.22.006. |
| [24] | 傅月美, 胡芳琳, 马建英, 等. 肺癌患者心理脆弱现状及影响因素分析. 现代实用医学, 2022, 34(5): 643-646. doi:10.3969/j.issn.1671-0800.2021.05.034. |
| [25] | Si Q, Guo J, Feng Y, et al. Correlation between depression and adherence to respiratory function exercise in elderly frail patients with tuberculosis: A cross-sectional survey. Medicine(Baltimore), 2024, 103(22): e38212. doi:10.1097/MD.0000000000038212. |
| [26] | Pradhan A, Koirala P, Bhandari SS, et al. Internalized and Perceived Stigma and Depression in Pulmonary Tuberculosis: Do They Explain the Relationship Between Drug Sensitivity Status and Adherence?. Front Psychiatry, 2022, 13: 869647. doi:10.3389/fpsyt.2022.869647. |
| [27] | Liebenberg D, Gordhan BG, Kana BD. Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management. Front Cell Infect Microbiol, 2022, 12: 943545. doi:10.3389/fcimb.2022.943545. |
| [28] |
Redwood L, Mitchell EMH, Viney K, et al. Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam. Int J Tuberc Lung Dis, 2021, 25(6): 461-467. doi:10.5588/ijtld.20.0952.
pmid: 34049608 |
| [29] | Shewade HD, Ravichandran P, Satish S, et al. Effect of glycemic control and type of diabetes treatment on TB treatment outcomes among people with TB-diabetes: A systematic review (updated August 2024). PLoS One, 2025, 20(7): e0328619. doi:10.1371/journal.pone.0328619. |
| [30] | 曾谊, 兰学立, 路希维. 重视结核病相关疾病的整合医学管理. 中国防痨杂志, 2024, 46(7): 735-738. doi:10.19982/j.issn.1000-6621.20240173. |
| [31] | 马志涛, 王娜, 吕阳, 等. 上海市宝山区肺结核患者心理状态及其影响因素分析. 中国防痨杂志, 2021, 43(4): 378-384. doi:10.3969/j.issn.1000-6621.2021.04.014. |
| [32] | Guo C, Wu Y, Bai X, et al. Association of health literacy with illness perception of Chinese community patients with chronic disease. BMC Public Health, 2025, 25(1): 1857. doi:10.1186/s12889-025-23123-2. |
| [33] | Janitra FE, Chen R, Lin HC, et al. Efficacy of resilience-related psychological interventions in patients with long-term diseases: A meta-analysis of randomised controlled trials. Int J Ment Health Nurs, 2024, 33(5):1388-1406. doi:10.1111/inm.13334. |
| [34] | Schnell T, Kehring A, Moritz S, et al. Patients responses to diagnoses of mental disorders: Development and validation of a reliable self-report measure. Int J Methods Psychiatr Res, 2021, 30(1):e1854. doi:10.1002/mpr.1854. |
| [1] | Gao Li, Zhang Guoqin. Current status and optimization paths of latent tuberculosis infection screening in patients with rheumatic immune diseases in China [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 561-566. |
| [2] | Huang Guojun, Wang Qiqi, Zheng Wenjing, Liu Jianjun, Bai Liqiong, Liang Jun, Yu Shicheng, Xu Zuhui, Wan Yanping, Liu Xie, Yao Hongyan, Ming Hui. Trend of pulmonary tuberculosis reported incidence in Hunan Province from 2009 to 2023: a population-based study using Joinpoint regression model [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 567-575. |
| [3] | Che Yang, Zhang Dongliang, Li Xiangchen, Lu Yewei, Liu Zhengwei. Molecular characterization and risk factors of cross-resistance between isoniazid and prothionamide in multidrug-resistant Mycobacterium tuberculosis in Ningbo, China [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 576-585. |
| [4] | Sun Zheng, Liu Jiongya, Chen Chi, Yu Quanji, Li Yanan, Chen Cheng, Zhu Limei. Study on the application of AI-assisted CT reading system in early detection of pulmonary tuberculosis in general hospitals [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 586-593. |
| [5] | Xie Cifu, Yin Pengliang, Song Lixin, Xiong Zi. Analysis of out-of-pocket medical expenses and influencing factors of multidrug-resistant/rifampicin-resistant pulmonary tuberculosis patients in Changsha City [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 594-602. |
| [6] | Wu Yaning, Huang Misun, Guo Yi, Bo Xianglong, Wang Ruihuan, Xing Jianliang, Fan Xueting, Xu Da, Zhao Lili, Zhao Xiuqin, Li Guilian, Liu Haican, Li Machao. Analysis of genetic mutation characteristics associated with linezolid resistance in Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 603-615. |
| [7] | Wu Gang, Zhang Zhengbin, Lu Zhouqin, Wang Xiaojun, Zhou Meilan, Li Yuehua. Comparison of clinical application effect between a novel fluorescent probe-based PCR method and three laboratory methods for detecting the Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 616-620. |
| [8] | Huang Jun, Du Zhixiang, Hu Chunmei. Influence factors of metabolic dysfunction-associated fatty liver disease on short-term effectiveness of anti-tuberculosis therapy in primary pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 631-640. |
| [9] | Zhang Shanshan, Han Yaxuan, Zhang Xiaoyan, Li Jianying, Ren Fei, Zhang Yaohui, Yang Haixia. Clinical characteristics and survival analysis of patients with lung cancer concurrent with drug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 641-650. |
| [10] | Gao Dan, Yao Liwei, Huang Jinpeng, Liu Xiaoxia, Zhang Yue, Ling Lin. Evidence summary on hospital-family digital health management with integrated traditional Chinese and Western medicine for tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 661-669. |
| [11] | Zhao Xiaoting, Han Jing, Hou Zhili, Ding Wenlong, Zhang Yuyang, Zhang Shuo, Xing Zhiheng. Predictive value of baseline chest CT features for anti-tuberculosis treatment outcomes in patients with non-drug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 670-676. |
| [12] | Yang Bin, Cao Yuqing, Zong Xingyu, Wang Chaohong, Zhao Liping, Su Dahong, Gong Mengmeng, Ma Yan, Shi Yiheng, Lin Weibing, Zhao Jinfeng, Cheng Simin, Miao Tiantian, Wang Guirong. Mechanism of Tounong San in abscess-type lymph node tuberculosis treatment using network pharmacology [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 677-686. |
| [13] | Li Qin, Li Linhong, Liu Jiao, Feng Mei, Xie Qi, Zhang Guixian, Yang Qiong, Yang Dandan. A case of AIDS with rifampicin-resistant tuberculous breast abscess and literature review [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 687-693. |
| [14] | Hu Xinyang, Liu Yang, Gao Jingtao. Research progress on latent tuberculosis infection in patients with hematological malignancies [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 694-699. |
| [15] | Shan Liyan, Li Longfen, Li Wenming, Luo Yun, Zhang Huajie, Wang Ge, Huang Yuanqing, Li Shan, Wu Huachao, Shi Chunjing, Shen Lingjun. Research progress of digital twin technology in tuberculosis prevention and control [J]. Chinese Journal of Antituberculosis, 2026, 48(5): 700-706. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.